RG
IOVA icon

Rathbones Group’s Iovance Biotherapeutics IOVA Stock Holding History

Rathbones Group’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$45.1K Hold
12,854
– – ﹤0.01% 636
2025
Q4 		$35.1K Sell
12,854
-300
-2% -$694 ﹤0.01% 624
2025
Q3 		$28.5K Hold
13,154
– – ﹤0.01% 633
2025
Q2 		$22.6K Sell
13,154
-60,000
-82% -$149K ﹤0.01% 620
2025
Q1 		$244K Hold
73,154
– – ﹤0.01% 498
2024
Q4 		$541K Hold
73,154
– – ﹤0.01% 405
2024
Q3 		$687K Hold
73,154
– – ﹤0.01% 371
2024
Q2 		$587K Hold
73,154
– – ﹤0.01% 389
2024
Q1 		$1.08M Buy
73,154
+2,000
+3% +$23.3K 0.01% 318
2023
Q4 		$578K Hold
71,154
– – ﹤0.01% 376
2023
Q3 		$324K Buy
+71,154
New +$465K ﹤0.01% 463

Other funds holding IOVA

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
MFM
MHR Fund Management New York $1.37B AUM 68.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.17B AUM 0.03% 1-Year Est. Return